κORs have shown promise as a potential drug target for substance use and mood disorders (Bruchas et al., 2010; Van't Veer and Carlezon, 2013; Crowley and Kash, 2015) and our work suggests a novel way in which κOR signaling may go awry. The gene discussed is OPRK1; the disease is mood disorder.